Literature DB >> 27578473

Inhalation device requirements for patients' inhalation maneuvers.

Peter Haidl1, Stefan Heindl2, Karsten Siemon1, Maria Bernacka3, Rolf Michael Cloes4.   

Abstract

BACKGROUND: Inhaled drugs are the mainstay of treatment for lung diseases such as asthma and chronic obstructive pulmonary disease. However, failure to use inhalation devices correctly can lead to a poorly controlled status. A vast number of inhalation devices exist and each device has specific requirements to achieve optimum inhalation of the drug. Currently, there is no overview of inhalation requirements considering all devices. This article presents a review of the literature on different inhalation device requirements and incorporates the data into a new inhalation flow algorithm.
METHODS: Data from literature on commercially available inhalation devices were evaluated and parameters, such as inhalation flow rate, flow acceleration, inhalation volume, and inspiration time assessed for the required inhalation maneuver specific to the device. All agreed upon data points were used to develop an inhalation flow algorithm.
RESULTS: The literature analysis revealed availability of robust data for the required inhalation flow characteristics for most devices and thus for the development of an algorithm. For those devices for which these parameters are not published, the minimum required flow criteria were defined based on published data regarding individual aspects of aerosol quality.
CONCLUSIONS: This review provides an overview of inhalation devices available on the market regarding requirements for an acceptable inhalation maneuver and shows which goals should be achieved in terms of inhalation flows. The presented algorithm can be used to develop a new computer based measurement system which could help to test and train patients' individual inhalation maneuvers with their inhalation devices.
Copyright © 2016 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Drug delivery; Inhalation device; Inhalation maneuver; Inhalation maneuver quality; Inspiratory flow rate

Mesh:

Substances:

Year:  2016        PMID: 27578473     DOI: 10.1016/j.rmed.2016.07.013

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  28 in total

1.  Patient characteristics associated with poor inhaler technique among a cohort of patients with COPD.

Authors:  Anne C Melzer; Bijan J Ghassemieh; Suzanne E Gillespie; Peter K Lindenauer; Mary Ann McBurnie; Richard A Mularski; Edward T Naureckas; William M Vollmer; David H Au
Journal:  Respir Med       Date:  2016-12-20       Impact factor: 3.415

Review 2.  Peak Inspiratory Flow Rate in Chronic Obstructive Pulmonary Disease: Implications for Dry Powder Inhalers.

Authors:  Sohini Ghosh; Jill A Ohar; M Bradley Drummond
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2017-09-21       Impact factor: 2.849

3.  The Repeatability of Inspiration Performance Through Different Inhalers in Patients with Chronic Obstructive Pulmonary Disease and Control Volunteers.

Authors:  Tamas Erdelyi; Zsofia Lazar; Balazs Odler; Lilla Tamasi; Veronika Müller
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2020-05-28       Impact factor: 2.849

4.  Spirometry Measurement of Peak Inspiratory Flow Identifies Suboptimal Use of Dry Powder Inhalers in Ambulatory Patients with COPD.

Authors:  Alexander G Duarte; Leon Tung; Wei Zhang; En Shuo Hsu; Yong-Fang Kuo; Gulshan Sharma
Journal:  Chronic Obstr Pulm Dis       Date:  2019-07-24

Review 5.  Performance Characteristics of Breezhaler® and Aerolizer® in the Real-World Setting.

Authors:  Mathieu Molimard; Ioannis Kottakis; Juergen Jauernig; Sonja Lederhilger; Ivan Nikolaev
Journal:  Clin Drug Investig       Date:  2021-03-25       Impact factor: 2.859

Review 6.  Spacer devices for inhaled therapy: why use them, and how?

Authors:  Walter Vincken; Mark L Levy; Jane Scullion; Omar S Usmani; P N Richard Dekhuijzen; Chris J Corrigan
Journal:  ERJ Open Res       Date:  2018-06-18

7.  Prevalence and factors associated with suboptimal peak inspiratory flow rates in COPD.

Authors:  Sohini Ghosh; Roy A Pleasants; Jill A Ohar; James F Donohue; M Bradley Drummond
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-03-01

Review 8.  Diagnosis and management of chronic obstructive pulmonary disease in Serbia: an expert group position statement.

Authors:  Marija Vukoja; Ivan Kopitovic; Zorica Lazic; Branislava Milenkovic; Ivana Stankovic; Biljana Zvezdin; Aleksandra Dudvarski Ilic; Ivan Cekerevac; Miodrag Vukcevic; Vladimir Zugic; Sanja Hromis
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-09-02

9.  Peak-Inspiratory-Flow-Rate Guided Inhalation Therapy Reduce Severe Exacerbation of COPD.

Authors:  Shih-Yu Chen; Chun-Kai Huang; Hui-Chuan Peng; Hsing-Chen Tsai; Szu-Ying Huang; Chong-Jen Yu; Jung-Yien Chien
Journal:  Front Pharmacol       Date:  2021-06-29       Impact factor: 5.810

Review 10.  Guiding Inspiratory Flow: Development of the In-Check DIAL G16, a Tool for Improving Inhaler Technique.

Authors:  Mark Jeremy Sanders
Journal:  Pulm Med       Date:  2017-11-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.